Charles River Laboratories CRL Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's total liabilities?
- Charles River Laboratories (CRL) reported total liabilities of $30M in Q1 2026.
- How has Charles River Laboratories's total liabilities changed year-over-year?
- Charles River Laboratories's total liabilities decreased by 99.3% year-over-year, from $4.34B to $30M.
- What is the long-term trend for Charles River Laboratories's total liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's total liabilities has grown at a -61.1% compound annual growth rate (CAGR), from $3.35B to $30M.
- What does total liabilities mean?
- The total amount of money a company owes to all creditors and lenders.
- How do you interpret total liabilities?
- An increase may signal aggressive expansion or liquidity pressure, while a decrease suggests debt repayment or deleveraging.
- How does total liabilities compare across companies?
- Peers in the contract research organization industry typically maintain moderate leverage ratios relative to their asset base.